Literature DB >> 20686488

Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species--ERK/JNK pathways.

Naro Ohashi1, Maki Urushihara, Ryousuke Satou, Hiroyuki Kobori.   

Abstract

Whereas intra-renal angiotensinogen is predominantly localized in proximal tubular cells under basal conditions, it has been previously reported that angiotensinogen expression is induced in glomeruli under pathological conditions. However, there is no detailed information regarding the mechanism of the induced glomerular angiotensinogen. We used genetic pairs of Zucker diabetic fatty (ZDF) obese and lean rats to determine glomerular angiotensinogen expression. The levels of glomerular angiotensinogen immunoreactivity in ZDF obese rats were higher than those in ZDF lean rats. Double staining by IHC or IF with angiotensinogen and Thy1.1 antibodies showed that the majority of angiotensinogen in glomeruli was seen in mesangial cells. The levels of glomerular immunoreactivity for 4-HNE and urinary excretion of 8-isoprostane-markers of ROS-in ZDF obese rats were higher than those in ZDF lean rats. To confirm this system, primary rat mesangial cells were treated with hydrogen peroxide (H₂O₂) to clarify the signal transduction pathway for glomerular angiotensinogen expression. H₂O₂ induced an increase in angiotensinogen expression in a dose- and time-dependent manner, and the H₂O₂-induced upregulation of angiotensinogen was suppressed by catalase. Furthermore, the H₂O₂-induced upregulation of angiotensinogen was inhibited by a mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitor and a c-Jun N-terminal kinase (JNK) inhibitor, but not inhibited by a p38 MAPK inhibitor. These data suggest that the majority of angiotensinogen was induced in mesangial cells in glomeruli under pathological conditions such as diabetic nephropathy, and angiotensinogen expression in mesangial cells was mediated by H₂O₂ and the subsequent activation of extracellular-regulated kinase (ERK)/JNK pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686488      PMCID: PMC2974762          DOI: 10.1038/hr.2010.143

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  41 in total

1.  IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal.

Authors:  C Ji; K R Kozak; L J Marnett
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

2.  Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Authors:  H Kobori; L M Harrison-Bernard; L G Navar
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

Review 3.  Podocyte biology and the emerging understanding of podocyte diseases.

Authors:  Laura Barisoni; Peter Mundel
Journal:  Am J Nephrol       Date:  2003-08-12       Impact factor: 3.754

4.  Importance of post-transcriptional regulation of chemokine genes by oxidative stress.

Authors:  C Josse; J R Boelaert; M Best-Belpomme; J Piette
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

5.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes.

Authors:  A Montero; K A Munger; R Z Khan; J M Valdivielso; J D Morrow; A Guasch; F N Ziyadeh; K F Badr
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

7.  Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

8.  Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose.

Authors:  Rekha Singh; Ashok K Singh; Nahid Alavi; David J Leehey
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

9.  In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys.

Authors:  I A Darby; C Sernia
Journal:  Cell Tissue Res       Date:  1995-08       Impact factor: 5.249

10.  High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells.

Authors:  Tusty-Jiuan Hsieh; Shao-Ling Zhang; Janos G Filep; Shiow-Shih Tang; Julie R Ingelfinger; John S D Chan
Journal:  Endocrinology       Date:  2002-08       Impact factor: 4.736

View more
  33 in total

1.  Urinary angiotensinogen increases in the absence of overt renal injury in high fat diet-induced type 2 diabetic mice.

Authors:  Virginia Reverte; Venkateswara R Gogulamudi; Carla B Rosales; Diego C Musial; Sabrina R Gonsalez; Alberto J Parra-Vitela; Michelle Galeas-Pena; Venkata N Sure; Bruna Visniauskas; Sarah H Lindsey; Prasad V G Katakam; Minolfa C Prieto
Journal:  J Diabetes Complications       Date:  2019-10-05       Impact factor: 2.852

2.  Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.

Authors:  Maki Urushihara; Hiroyuki Kobori
Journal:  Int J Clin Med       Date:  2011-09-01

3.  Advanced Glycation End Products Stimulate Angiotensinogen Production in Renal Proximal Tubular Cells.

Authors:  Joseph M Garagliano; Akemi Katsurada; Kayoko Miyata; Andrei V Derbenev; Andrea Zsombok; L Gabriel Navar; Ryousuke Satou
Journal:  Am J Med Sci       Date:  2018-10-24       Impact factor: 2.378

4.  Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.

Authors:  Maki Urushihara; Takashi Nagai; Yukiko Kinoshita; Sato Nishiyama; Kenichi Suga; Natsuko Ozaki; Ariunbold Jamba; Shuji Kondo; Hiroyuki Kobori; Shoji Kagami
Journal:  Pediatr Nephrol       Date:  2014-12-20       Impact factor: 3.714

5.  Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells.

Authors:  Ryousuke Satou; Michael W Cypress; T Cooper Woods; Akemi Katsurada; Courtney M Dugas; Vivian A Fonseca; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2019-11-04

6.  NADPH oxidase inhibition reduces tubular sodium transport and improves kidney oxygenation in diabetes.

Authors:  Patrik Persson; Peter Hansell; Fredrik Palm
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-05-02       Impact factor: 3.619

7.  Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney.

Authors:  Masumi Kamiyama; Kristina M Farragut; Michelle K Garner; L Gabriel Navar; Hiroyuki Kobori
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

8.  ROCK/NF-κB axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells.

Authors:  Kayoko Miyata; Ryousuke Satou; Weijian Shao; Minolfa C Prieto; Maki Urushihara; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15

9.  Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats.

Authors:  Weijian Shao; Kayoko Miyata; Akemi Katsurada; Ryousuke Satou; Dale M Seth; Carla B Rosales; Minolfa C Prieto; Kenneth D Mitchell; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

Review 10.  Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.

Authors:  Hiroyuki Kobori; Maki Urushihara
Journal:  Pflugers Arch       Date:  2012-08-24       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.